{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:10:15Z","timestamp":1784740215448,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jaad.2013.04.027","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T04:45:12Z","timestamp":1368679512000},"page":"375-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["A comprehensive immunohistochemical approach of AKT\/mTOR pathway and p-STAT3 in mycosis fungoides"],"prefix":"10.1016","volume":"69","author":[{"given":"Georgia","family":"Levidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Siakantaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Papadaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Papadavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros P.","family":"Vassilakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Angelopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Marinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aphroditi","family":"Economidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Patsouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Korkolopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.04.027_bib1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/PAS.0b013e3181bf677d","article-title":"CD30 expression and proliferative fraction in nontransformed mycosis fungoides","volume":"33","author":"Edinger","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2013.04.027_bib2","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1158\/0008-5472.CAN-06-0364","article-title":"AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling","volume":"66","author":"Riemenschneider","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2013.04.027_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway","volume":"10","author":"Manning","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.jaad.2013.04.027_bib4","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","article-title":"The mTOR signaling pathway in human cancer","volume":"13","author":"P\u00f3pulo","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaad.2013.04.027_bib5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1101\/gad.13.9.1203","article-title":"The bHLH gene Hes1 is essential for expansion of early T cell precursors","volume":"13","author":"Tomita","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.jaad.2013.04.027_bib6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4161\/cc.7.8.5753","article-title":"The role of the PTEN\/AKT pathway in NOTCH1-induced leukemia","volume":"7","author":"Palomero","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jaad.2013.04.027_bib7","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1038\/sj.onc.1207590","article-title":"Signaling control of mRNA translation in cancer pathogenesis","volume":"23","author":"Holland","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jaad.2013.04.027_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0960-9822(99)00268-7","article-title":"Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR","volume":"10","author":"Yokogami","year":"2000","journal-title":"Curr Biol"},{"key":"10.1016\/j.jaad.2013.04.027_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2567.2005.02091.x","article-title":"Signal transducer and activator of transcription (STAT) signaling and T-cell lymphomas","volume":"114","author":"Mitchell","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.jaad.2013.04.027_bib10","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1182\/blood.V99.8.2929","article-title":"The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells","volume":"99","author":"Berger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.04.027_bib11","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.04.027_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1158\/1078-0432.CCR-06-1560","article-title":"4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis","volume":"13","author":"Rojo","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2013.04.027_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2559.2012.04236.x","article-title":"Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas","volume":"61","author":"Korkolopoulou","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.jaad.2013.04.027_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11912-011-0187-7","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in non-Hodgkin's lymphoma: results, biology, and development strategies","volume":"13","author":"Schatz","year":"2011","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jaad.2013.04.027_bib15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1517\/13543784.2011.541154","article-title":"Current and future directions in mammalian target of rapamycin inhibitors development","volume":"20","author":"Fasolo","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaad.2013.04.027_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.beha.2012.04.008","article-title":"Targeting mTOR in mantle cell lymphoma: current and future directions","volume":"25","author":"Smith","year":"2012","journal-title":"Best Pract Res Clin Haematol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2013.04.027_bib17","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1053\/j.seminoncol.2009.10.012","article-title":"Temsirolimus in mantle cell lymphoma and other non-Hodgkin lymphoma subtypes","volume":"36","author":"Hess","year":"2009","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jaad.2013.04.027_bib18","doi-asserted-by":"crossref","first-page":"e24849","DOI":"10.1371\/journal.pone.0024849","article-title":"Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells","volume":"6","author":"Marzec","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2013.04.027_bib19","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1038\/cddis.2012.13","article-title":"Therapeutic metformin\/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy","volume":"3","author":"Shi","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jaad.2013.04.027_bib20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1600-0625.2010.01102.x","article-title":"Cutaneous T-cell lymphoma cells are sensitive to rapamycin","volume":"19","author":"Kremer","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.04.027_bib21","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood-2007-06-095182","article-title":"IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes","volume":"111","author":"Marzec","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.04.027_bib22","doi-asserted-by":"crossref","first-page":"50402","DOI":"10.1074\/jbc.M307627200","article-title":"Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT\/survivin pathway","volume":"278","author":"Fornaro","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2013.04.027_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cncr.23996","article-title":"Critical and diverse involvement of Akt\/mammalian target of rapamycin signaling in human lung carcinomas","volume":"115","author":"Dobashi","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2013.04.027_bib24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jamcollsurg.2009.12.008","article-title":"Novel expression patterns of PI3K\/Akt\/mTOR signaling pathway components in colorectal cancer","volume":"210","author":"Johnson","year":"2010","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jaad.2013.04.027_bib25","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1002\/cncr.25502","article-title":"Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy","volume":"116","author":"Schultz","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2013.04.027_bib26","doi-asserted-by":"crossref","first-page":"E1237","DOI":"10.1111\/j.1464-410X.2012.11569.x","article-title":"A comprehensive immunohistochemical and molecular approach to pi3k\/akt\/mtor pathway in bladder carcinoma","volume":"110","author":"Korkolopoulou","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.jaad.2013.04.027_bib27","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-2559.2011.03856.x","article-title":"Activation of the PI3K\/Akt\/mTOR pathway correlates with tumor progression and reduced survival in patients with urothelial carcinoma of the urinary bladder","volume":"58","author":"Sun","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.jaad.2013.04.027_bib28","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/cncr.22195","article-title":"Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer","volume":"107","author":"Castellvi","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2013.04.027_bib29","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1128\/MCB.25.7.2558-2572.2005","article-title":"Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins","volume":"25","author":"Wang","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaad.2013.04.027_bib30","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/01.jnen.0000248549.14962.b2","article-title":"Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival","volume":"65","author":"Mizoguchi","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jaad.2013.04.027_bib31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2133.2010.09915.x","article-title":"Notch signaling in primary cutaneous CD30+ lymphoproliferative disorders: a new therapeutic approach?","volume":"163","author":"Kamstrup","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.04.027_bib32","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood.V99.9.3398","article-title":"Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma","volume":"99","author":"Jundt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.04.027_bib33","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1158\/0008-5472.CAN-05-1069","article-title":"High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival","volume":"65","author":"Reedijk","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2013.04.027_bib34","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1172\/JCI25001","article-title":"Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression","volume":"115","author":"Balint","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2013.04.027_bib35","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1182\/blood-2003-07-2254","article-title":"Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells","volume":"103","author":"Jundt","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.04.027_bib36","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood-2008-02-139725","article-title":"Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells","volume":"113","author":"Rosati","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.04.027_bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/10428190109064603","article-title":"Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells","volume":"42","author":"Tohda","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaad.2013.04.027_bib38","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s12032-009-9365-y","article-title":"mTOR\/p70S6K signal transduction pathway contributes to osteosarcoma progression and patients' prognosis","volume":"27","author":"Zhou","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.jaad.2013.04.027_bib39","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1200\/JCO.2005.23.622","article-title":"Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a north central cancer treatment group study","volume":"23","author":"Galanis","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2013.04.027_bib40","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.2174\/092986711796011201","article-title":"Targeting the phosphatidylinositol 3-kinase\/Akt\/mammalian target of rapamycin signaling network in cancer stem cells","volume":"18","author":"Martelli","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jaad.2013.04.027_bib41","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organization for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2013.04.027_bib42","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaad.2009.03.014","article-title":"Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases","volume":"62","author":"Muniesa","year":"2010","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213004143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213004143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:28:06Z","timestamp":1759271286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213004143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0190962213004143"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.04.027","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive immunohistochemical approach of AKT\/mTOR pathway and p-STAT3 in mycosis fungoides","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}